Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichom...
Gespeichert in:
| Veröffentlicht in: | PloS one 2015-12, Vol.10 (12), p.e0143304-e0143304 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0143304 |
|---|---|
| container_issue | 12 |
| container_start_page | e0143304 |
| container_title | PloS one |
| container_volume | 10 |
| creator | Newman, Lori Rowley, Jane Vander Hoorn, Stephen Wijesooriya, Nalinka Saman Unemo, Magnus Low, Nicola Stevens, Gretchen Gottlieb, Sami Kiarie, James Temmerman, Marleen |
| description | Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis.
WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2% (95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8% (0.6-1.0%), trichomoniasis 5.0% (4.0-6.4%), and syphilis 0.5% (0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6% (0.4-0.9%), trichomoniasis 0.6% (0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex.
Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level. |
| doi_str_mv | 10.1371/journal.pone.0143304 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1746865243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A436862779</galeid><doaj_id>oai_doaj_org_article_9638caf701af444591fbc4fea3d80540</doaj_id><sourcerecordid>A436862779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c795t-7c6fffae2ba77fa2a3470fc963b81527addf02257ee326a8e2bf3954309698043</originalsourceid><addsrcrecordid>eNqNk91u1DAQhSMEolB4AwSWkBBI7OLYTpzcIJXSlpUqFbWlt5bjjHddee0ldvrzJjwu3uy2alAvUC6SeL45ZzKZybI3OZ7mlOdfLn3fOWmnK-9ginNGKWZPshd5TcmkJJg-ffC8k70M4RLjglZl-TzbIWXJyoLlL7I_R9Y30qKDEM1SRgjIaxQXgH52cCUtOAVIuhbNnDLt8Jbih8ka7fedbCygM7jppbW36LyTLixNjLDGNahovAvIOERwTtA3GVLAO3R2GyIkL6PQKVwZuB4MtnWcwsp30bj5q-yZljbA6-19N_t1eHC-_2NyfHI02987niheF3HCVam1lkAaybmWRFLGsVZ1SZsqLwiXbasxIQUHoKSUVQI1rQtGcV3WFWZ0N3u30V1ZH8S2qUHknJVVWZDU1t1stiFaLy_Fqkt96m6Fl0YMB76bC5lKVhZEsq2U1BznUjPGijrXjWIaJG0rXDCctD5vtMI1rPpmpPbdXOwNar7rBeNlnSf867a4vllCq8DFTtpR1jjizELM_ZVgJScVr5PAx61A53_3EKJYmqDAWunA98NncpoTRtZe7_9BH2_Glpqn4RDGaZ981VpU7DGaKMIH2-kjVLpaWBqVBlabdD5K-DRKSEyEmziXfQhidnb6_-zJxZj98IBdgLRxEbzth9Ecg2wDqs6H0IG-b3KOxXrf7roh1vsmtvuW0t4-_EH3SXcLRv8CbWUmTA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1746865243</pqid></control><display><type>article</type><title>Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting</title><source>Electronic Journals Library</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PLoS_OA刊</source><source>PubMed Central</source><source>SWEPUB Freely available online</source><source>Free Full-Text Journals in Chemistry</source><creator>Newman, Lori ; Rowley, Jane ; Vander Hoorn, Stephen ; Wijesooriya, Nalinka Saman ; Unemo, Magnus ; Low, Nicola ; Stevens, Gretchen ; Gottlieb, Sami ; Kiarie, James ; Temmerman, Marleen</creator><creatorcontrib>Newman, Lori ; Rowley, Jane ; Vander Hoorn, Stephen ; Wijesooriya, Nalinka Saman ; Unemo, Magnus ; Low, Nicola ; Stevens, Gretchen ; Gottlieb, Sami ; Kiarie, James ; Temmerman, Marleen</creatorcontrib><description>Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis.
WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2% (95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8% (0.6-1.0%), trichomoniasis 5.0% (4.0-6.4%), and syphilis 0.5% (0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6% (0.4-0.9%), trichomoniasis 0.6% (0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex.
Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0143304</identifier><identifier>PMID: 26646541</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Bayesian analysis ; Care and treatment ; Chlamydia ; Chlamydia trachomatis ; Complications and side effects ; Disease transmission ; Epidemiology ; Estimates ; Female ; Geography ; Global Health ; Humans ; Incidence ; Infections ; Infectious Diseases ; Infektionssjukdomar ; Laboratory tests ; Literature reviews ; Male ; Prevalence ; Prevalence studies (Epidemiology) ; Public health ; Regional analysis ; Risk factors ; Serology ; Sexually transmitted diseases ; Sexually Transmitted Diseases - drug therapy ; Sexually Transmitted Diseases - epidemiology ; STD ; Subpopulations ; Syphilis ; Systematic review ; Trichomonas vaginalis ; Trichomoniasis ; Womens health</subject><ispartof>PloS one, 2015-12, Vol.10 (12), p.e0143304-e0143304</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”) Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c795t-7c6fffae2ba77fa2a3470fc963b81527addf02257ee326a8e2bf3954309698043</citedby><cites>FETCH-LOGICAL-c795t-7c6fffae2ba77fa2a3470fc963b81527addf02257ee326a8e2bf3954309698043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672879/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672879/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26646541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-47691$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Newman, Lori</creatorcontrib><creatorcontrib>Rowley, Jane</creatorcontrib><creatorcontrib>Vander Hoorn, Stephen</creatorcontrib><creatorcontrib>Wijesooriya, Nalinka Saman</creatorcontrib><creatorcontrib>Unemo, Magnus</creatorcontrib><creatorcontrib>Low, Nicola</creatorcontrib><creatorcontrib>Stevens, Gretchen</creatorcontrib><creatorcontrib>Gottlieb, Sami</creatorcontrib><creatorcontrib>Kiarie, James</creatorcontrib><creatorcontrib>Temmerman, Marleen</creatorcontrib><title>Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis.
WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2% (95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8% (0.6-1.0%), trichomoniasis 5.0% (4.0-6.4%), and syphilis 0.5% (0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6% (0.4-0.9%), trichomoniasis 0.6% (0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex.
Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Bayesian analysis</subject><subject>Care and treatment</subject><subject>Chlamydia</subject><subject>Chlamydia trachomatis</subject><subject>Complications and side effects</subject><subject>Disease transmission</subject><subject>Epidemiology</subject><subject>Estimates</subject><subject>Female</subject><subject>Geography</subject><subject>Global Health</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious Diseases</subject><subject>Infektionssjukdomar</subject><subject>Laboratory tests</subject><subject>Literature reviews</subject><subject>Male</subject><subject>Prevalence</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Public health</subject><subject>Regional analysis</subject><subject>Risk factors</subject><subject>Serology</subject><subject>Sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - drug therapy</subject><subject>Sexually Transmitted Diseases - epidemiology</subject><subject>STD</subject><subject>Subpopulations</subject><subject>Syphilis</subject><subject>Systematic review</subject><subject>Trichomonas vaginalis</subject><subject>Trichomoniasis</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><sourceid>DOA</sourceid><recordid>eNqNk91u1DAQhSMEolB4AwSWkBBI7OLYTpzcIJXSlpUqFbWlt5bjjHddee0ldvrzJjwu3uy2alAvUC6SeL45ZzKZybI3OZ7mlOdfLn3fOWmnK-9ginNGKWZPshd5TcmkJJg-ffC8k70M4RLjglZl-TzbIWXJyoLlL7I_R9Y30qKDEM1SRgjIaxQXgH52cCUtOAVIuhbNnDLt8Jbih8ka7fedbCygM7jppbW36LyTLixNjLDGNahovAvIOERwTtA3GVLAO3R2GyIkL6PQKVwZuB4MtnWcwsp30bj5q-yZljbA6-19N_t1eHC-_2NyfHI02987niheF3HCVam1lkAaybmWRFLGsVZ1SZsqLwiXbasxIQUHoKSUVQI1rQtGcV3WFWZ0N3u30V1ZH8S2qUHknJVVWZDU1t1stiFaLy_Fqkt96m6Fl0YMB76bC5lKVhZEsq2U1BznUjPGijrXjWIaJG0rXDCctD5vtMI1rPpmpPbdXOwNar7rBeNlnSf867a4vllCq8DFTtpR1jjizELM_ZVgJScVr5PAx61A53_3EKJYmqDAWunA98NncpoTRtZe7_9BH2_Glpqn4RDGaZ981VpU7DGaKMIH2-kjVLpaWBqVBlabdD5K-DRKSEyEmziXfQhidnb6_-zJxZj98IBdgLRxEbzth9Ecg2wDqs6H0IG-b3KOxXrf7roh1vsmtvuW0t4-_EH3SXcLRv8CbWUmTA</recordid><startdate>20151208</startdate><enddate>20151208</enddate><creator>Newman, Lori</creator><creator>Rowley, Jane</creator><creator>Vander Hoorn, Stephen</creator><creator>Wijesooriya, Nalinka Saman</creator><creator>Unemo, Magnus</creator><creator>Low, Nicola</creator><creator>Stevens, Gretchen</creator><creator>Gottlieb, Sami</creator><creator>Kiarie, James</creator><creator>Temmerman, Marleen</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>AABEP</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>D91</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20151208</creationdate><title>Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting</title><author>Newman, Lori ; Rowley, Jane ; Vander Hoorn, Stephen ; Wijesooriya, Nalinka Saman ; Unemo, Magnus ; Low, Nicola ; Stevens, Gretchen ; Gottlieb, Sami ; Kiarie, James ; Temmerman, Marleen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c795t-7c6fffae2ba77fa2a3470fc963b81527addf02257ee326a8e2bf3954309698043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Bayesian analysis</topic><topic>Care and treatment</topic><topic>Chlamydia</topic><topic>Chlamydia trachomatis</topic><topic>Complications and side effects</topic><topic>Disease transmission</topic><topic>Epidemiology</topic><topic>Estimates</topic><topic>Female</topic><topic>Geography</topic><topic>Global Health</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious Diseases</topic><topic>Infektionssjukdomar</topic><topic>Laboratory tests</topic><topic>Literature reviews</topic><topic>Male</topic><topic>Prevalence</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Public health</topic><topic>Regional analysis</topic><topic>Risk factors</topic><topic>Serology</topic><topic>Sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - drug therapy</topic><topic>Sexually Transmitted Diseases - epidemiology</topic><topic>STD</topic><topic>Subpopulations</topic><topic>Syphilis</topic><topic>Systematic review</topic><topic>Trichomonas vaginalis</topic><topic>Trichomoniasis</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Newman, Lori</creatorcontrib><creatorcontrib>Rowley, Jane</creatorcontrib><creatorcontrib>Vander Hoorn, Stephen</creatorcontrib><creatorcontrib>Wijesooriya, Nalinka Saman</creatorcontrib><creatorcontrib>Unemo, Magnus</creatorcontrib><creatorcontrib>Low, Nicola</creatorcontrib><creatorcontrib>Stevens, Gretchen</creatorcontrib><creatorcontrib>Gottlieb, Sami</creatorcontrib><creatorcontrib>Kiarie, James</creatorcontrib><creatorcontrib>Temmerman, Marleen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale_Opposing Viewpoints In Context</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Agriculture & Environmental Science Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Örebro universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Örebro universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Newman, Lori</au><au>Rowley, Jane</au><au>Vander Hoorn, Stephen</au><au>Wijesooriya, Nalinka Saman</au><au>Unemo, Magnus</au><au>Low, Nicola</au><au>Stevens, Gretchen</au><au>Gottlieb, Sami</au><au>Kiarie, James</au><au>Temmerman, Marleen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-12-08</date><risdate>2015</risdate><volume>10</volume><issue>12</issue><spage>e0143304</spage><epage>e0143304</epage><pages>e0143304-e0143304</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis.
WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2% (95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8% (0.6-1.0%), trichomoniasis 5.0% (4.0-6.4%), and syphilis 0.5% (0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6% (0.4-0.9%), trichomoniasis 0.6% (0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex.
Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26646541</pmid><doi>10.1371/journal.pone.0143304</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2015-12, Vol.10 (12), p.e0143304-e0143304 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1746865243 |
| source | Electronic Journals Library; MEDLINE; DOAJ Directory of Open Access Journals; PLoS_OA刊; PubMed Central; SWEPUB Freely available online; Free Full-Text Journals in Chemistry |
| subjects | Acquired immune deficiency syndrome AIDS Bayesian analysis Care and treatment Chlamydia Chlamydia trachomatis Complications and side effects Disease transmission Epidemiology Estimates Female Geography Global Health Humans Incidence Infections Infectious Diseases Infektionssjukdomar Laboratory tests Literature reviews Male Prevalence Prevalence studies (Epidemiology) Public health Regional analysis Risk factors Serology Sexually transmitted diseases Sexually Transmitted Diseases - drug therapy Sexually Transmitted Diseases - epidemiology STD Subpopulations Syphilis Systematic review Trichomonas vaginalis Trichomoniasis Womens health |
| title | Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A51%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Global%20Estimates%20of%20the%20Prevalence%20and%20Incidence%20of%20Four%20Curable%20Sexually%20Transmitted%20Infections%20in%202012%20Based%20on%20Systematic%20Review%20and%20Global%20Reporting&rft.jtitle=PloS%20one&rft.au=Newman,%20Lori&rft.date=2015-12-08&rft.volume=10&rft.issue=12&rft.spage=e0143304&rft.epage=e0143304&rft.pages=e0143304-e0143304&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0143304&rft_dat=%3Cgale_plos_%3EA436862779%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1746865243&rft_id=info:pmid/26646541&rft_galeid=A436862779&rft_doaj_id=oai_doaj_org_article_9638caf701af444591fbc4fea3d80540&rfr_iscdi=true |